Top Markets
Coin of the day
Solvonis Therapeutics plc Solvonis Therapeutics plc

Solvonis Therapeutics plc

SVNS
Xếp hạng trong cổ phiếu #40468
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January... Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with materials such as fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste. GRAFTALEN: These are reactive solid super-concentrates engineered to enhance polyolefin rheology, boost e-modulus, act as chain extenders for PET/PBT, and serve as AOX masterbatches. GRAFTAPOR: Comprising porous polymer-carriers, this line is specifically developed for applications involving liquid chemicals. GRAFTAMID: This series includes high-temperature elastomers, based on nanostructured polyolefin-polyamide alloys. They function as advanced hardening modifiers within polyamide compounds or as standalone components in hot melt adhesive formulations. GRAFTAKIT: Offering reactive liquid or solid super-concentrates embedded in polymeric porous media, GRAFTAKIT is used to optimize reaction extrusion and the modification of compounds. GRAFTALLOY: A range of polymer-polymer nano-alloys crafted to significantly improve abrasion and temperature resistance, boost impact strength, and reduce friction. GRAFTASYNT: This line encompasses synthetic products, notably including halogen-free flame retardants. GRAFTAMER: An innovative smart polymer characterized by thermo-reversible crosslinking, self-hardening, self-healing properties, and shape memory capabilities. The company was founded in 2017 and maintains its headquarters in London, United Kingdom.
Giá cổ phiếu
$0.00204105
Vốn hóa thị trường
$138.92K
Thay đổi (1 ngày)
5.63%
Thay đổi (1 năm)
-60.44%
Quốc gia
GB
Giao dịch Solvonis Therapeutics plc (SVNS)

Danh mục

Giá của SVNS với vốn hóa thị trường của B
Solvonis Therapeutics plc Solvonis Therapeutics plc
SVNS
$0.00204105
Vốn hóa thị trường của Solvonis Therapeutics plc(SVNS)
Vốn hóa thị trường: $138.92K
Tính đến năm August 2026, Solvonis Therapeutics plc có vốn hóa thị trường là $138.92K. Theo dữ liệu của chúng tôi, điều này khiến Solvonis Therapeutics plc trở thành công ty có giá trị lớn thứ 40468th trên thế giới theo vốn hóa thị trường. Vốn hóa thị trường là tổng giá trị thị trường của tất cả cổ phiếu đang lưu hành của một công ty niêm yết và thường được sử dụng để đo lường giá trị của công ty đó.
Lịch sử vốn hóa thị trường của Solvonis Therapeutics plc từ 2022 đến 2026
SVNS So với Top 5 phổ biến nhất stocks
Giá của SVNS Tài sản B Thị trường của B Kết quả
Solvonis Therapeutics plc Solvonis Therapeutics plc
$80,358.71 $138.92K
$5.470T +3,937,121,289.65%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$65,648.98 $138.92K
$4.468T +3,216,428,044.48%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$61,330.28 $138.92K
$4.174T +3,004,836,235.16%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$54,361.71 $138.92K
$3.700T +2,663,415,733.27%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$41,936.14 $138.92K
$2.854T +2,054,633,061.29%